99 related articles for article (PubMed ID: 27436274)
1. Coprogression of Cardiovascular Risk Factors in Type 1 Diabetes During 30 Years of Follow-up in the DCCT/EDIC Study.
Writing Group for the DCCT/EDIC Research Group
Diabetes Care; 2016 Sep; 39(9):1621-30. PubMed ID: 27436274
[TBL] [Abstract][Full Text] [Related]
2. The relationship of blood glucose with cardiovascular disease is mediated over time by traditional risk factors in type 1 diabetes: the DCCT/EDIC study.
Bebu I; Braffett BH; Pop-Busui R; Orchard TJ; Nathan DM; Lachin JM;
Diabetologia; 2017 Oct; 60(10):2084-2091. PubMed ID: 28711972
[TBL] [Abstract][Full Text] [Related]
3. Mortality in Type 1 Diabetes in the DCCT/EDIC Versus the General Population.
Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Group
Diabetes Care; 2016 Aug; 39(8):1378-83. PubMed ID: 27411699
[TBL] [Abstract][Full Text] [Related]
4. Patterns of Regional Brain Atrophy and Brain Aging in Middle- and Older-Aged Adults With Type 1 Diabetes.
Habes M; Jacobson AM; Braffett BH; Rashid T; Ryan CM; Shou H; Cui Y; Davatzikos C; Luchsinger JA; Biessels GJ; Bebu I; Gubitosi-Klug RA; Bryan RN; Nasrallah IM;
JAMA Netw Open; 2023 Jun; 6(6):e2316182. PubMed ID: 37261829
[TBL] [Abstract][Full Text] [Related]
5. Variability in benefit from intensive insulin therapy on cardiovascular events in individuals with type 1 diabetes: A post hoc analysis of the DCCT/EDIC study.
Helmink MAG; Hageman SHJ; Visseren FLJ; de Ranitz-Greven WL; de Valk HW; van Sloten TT; Westerink J
Diabet Med; 2023 Nov; 40(11):e15183. PubMed ID: 37470718
[TBL] [Abstract][Full Text] [Related]
6. The Beneficial Effects of Earlier Versus Later Implementation of Intensive Therapy in Type 1 Diabetes.
Lachin JM; Bebu I; Nathan DM;
Diabetes Care; 2021 Aug; 44(10):2225-30. PubMed ID: 34380706
[TBL] [Abstract][Full Text] [Related]
7. Differentiation of Diabetes by Pathophysiology, Natural History, and Prognosis.
Skyler JS; Bakris GL; Bonifacio E; Darsow T; Eckel RH; Groop L; Groop PH; Handelsman Y; Insel RA; Mathieu C; McElvaine AT; Palmer JP; Pugliese A; Schatz DA; Sosenko JM; Wilding JP; Ratner RE
Diabetes; 2017 Feb; 66(2):241-255. PubMed ID: 27980006
[TBL] [Abstract][Full Text] [Related]
8. Commentary on risk factors for first and subsequent cardiovascular disease events in type 1 diabetes: The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study.
Lin CH; Chang CH; Chuang LM
J Diabetes Investig; 2021 Mar; 12(3):313-316. PubMed ID: 32997888
[No Abstract] [Full Text] [Related]
9. Celebrating 30 years of research accomplishments of the diabetes control and complications trial/epidemiology of diabetes interventions and complications study.
Fradkin JE; Cowie CC; Hanlon MC; Rodgers GP
Diabetes; 2013 Dec; 62(12):3963-7. PubMed ID: 24264393
[No Abstract] [Full Text] [Related]
10. Diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: advances and contributions.
Nathan DM; Bayless M; Cleary P; Genuth S; Gubitosi-Klug R; Lachin JM; Lorenzi G; Zinman B;
Diabetes; 2013 Dec; 62(12):3976-86. PubMed ID: 24264395
[No Abstract] [Full Text] [Related]
11. Lingering Effects of Hyperglycemia in Recently Diagnosed Diabetes During Long-term Follow-up of the DCCT/EDIC and UKPDS Cohorts: More Evidence That Early Control Matters.
Riddle MC; Gerstein HC; Home PD
Diabetes Care; 2021 Sep; ():. PubMed ID: 34548282
[No Abstract] [Full Text] [Related]
12. Risk Factors for Cardiovascular Disease (CVD) in Adults with Type 1 Diabetes: Findings from Prospective Real-life T1D Exchange Registry.
Shah VN; Bailey R; Wu M; Foster NC; Pop-Busui R; Katz M; Crandall J; Bacha F; Nadeau K; Libman I; Hiers P; Mizokami-Stout K; DiMeglio LA; Sherr J; Pratley R; Agarwal S; Snell-Bergeon J; Cengiz E; Polsky S; Mehta SN
J Clin Endocrinol Metab; 2020 May; 105(5):e2032-8. PubMed ID: 31955209
[TBL] [Abstract][Full Text] [Related]
13. Association of Glycemic Variability in Type 1 Diabetes With Progression of Microvascular Outcomes in the Diabetes Control and Complications Trial.
Lachin JM; Bebu I; Bergenstal RM; Pop-Busui R; Service FJ; Zinman B; Nathan DM;
Diabetes Care; 2017 Jun; 40(6):777-783. PubMed ID: 28404658
[TBL] [Abstract][Full Text] [Related]
14. The Impact of Metabolic Memory on Immune Profile in Young Patients with Uncomplicated Type 1 Diabetes.
Neubauer-Geryk J; Wielicka M; Myśliwiec M; Zorena K; Bieniaszewski L
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542165
[TBL] [Abstract][Full Text] [Related]
15. Relationships Between the Cumulative Incidences of Long-term Complications in Type 1 Diabetes: The DCCT/EDIC Study.
Bebu I; Braffett BH; de Boer IH; Aiello LP; Bantle JP; Lorenzi GM; Herman WH; Gubitosi-Klug RA; Perkins BA; Lachin JM; Molitch ME
Diabetes Care; 2023 Feb; 46(2):361-368. PubMed ID: 36520643
[TBL] [Abstract][Full Text] [Related]
16. Role of advanced glycation end products on vascular smooth muscle cells under diabetic atherosclerosis.
Mao L; Yin R; Yang L; Zhao D
Front Endocrinol (Lausanne); 2022; 13():983723. PubMed ID: 36120471
[TBL] [Abstract][Full Text] [Related]
17. Cardiometabolic Risk Factors and Incident Cardiovascular Disease Events in Women vs Men With Type 1 Diabetes.
Braffett BH; Bebu I; El Ghormli L; Cowie CC; Sivitz WI; Pop-Busui R; Larkin ME; Gubitosi-Klug RA; Nathan DM; Lachin JM; Dagogo-Jack S;
JAMA Netw Open; 2022 Sep; 5(9):e2230710. PubMed ID: 36074461
[TBL] [Abstract][Full Text] [Related]
18. Physical Function in Middle-aged and Older Adults With Type 1 Diabetes: Long-term Follow-up of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study.
Martin CL; Trapani VR; Backlund JC; Lee P; Braffett BH; Bebu I; Lachin JM; Jacobson AM; Gubitosi-Klug R; Herman WH;
Diabetes Care; 2022 Sep; 45(9):2037-2045. PubMed ID: 35880807
[TBL] [Abstract][Full Text] [Related]
19. Brain Structure Among Middle-aged and Older Adults With Long-standing Type 1 Diabetes in the DCCT/EDIC Study.
Jacobson AM; Braffett BH; Erus G; Ryan CM; Biessels GJ; Luchsinger JA; Bebu I; Gubitosi-Klug RA; Desiderio L; Lorenzi GM; Trapani VR; Lachin JM; Bryan RN; Habes M; Nasrallah IM;
Diabetes Care; 2022 Aug; 45(8):1779-1787. PubMed ID: 35699949
[TBL] [Abstract][Full Text] [Related]
20. Joint 30-year HbA1c and lipid trajectories and mortality in type 1 diabetes.
Miller RG; Orchard TJ; Costacou T
Diabetes Res Clin Pract; 2022 Mar; 185():109787. PubMed ID: 35183647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
